
    
      PRIMARY OBJECTIVE:

      I. To evaluate if perioperative blood transfusions are associated with 1-year mortality.

      SECONDARY OBJECTIVES:

      I. To evaluate the association of blood transfusion with postoperative complications, 30 days
      mortality and cancer progression after major oncologic non-cardiac surgery.

      II. To gain knowledge on prevalence and patterns of blood product administration worldwide,
      the incidence and management of perioperative anemia and the incidence and treatment of
      perioperative coagulopathies.

      OUTLINE:

      Patients undergo standard of care treatment and their medical records are reviewed at 30 days
      and at 1 year after surgery.
    
  